S431-1039 Screening compound: {4-[cyclopropyl(4-fluorobenzyl)amino]-1-oxa-9-azaspiro[5.5]undec-9-yl}(1-methyl-1H-pyrazol-5-yl)methanone

S431-1039 Screening compound: {4-[cyclopropyl(4-fluorobenzyl)amino]-1-oxa-9-azaspiro[5.5]undec-9-yl}(1-methyl-1H-pyrazol-5-yl)methanone
S431-1039 Screening compound: {4-[cyclopropyl(4-fluorobenzyl)amino]-1-oxa-9-azaspiro[5.5]undec-9-yl}(1-methyl-1H-pyrazol-5-yl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound S431-1039
{4-[cyclopropyl(4-fluorobenzyl)amino]-1-oxa-9-azaspiro[5.5]undec-9-yl}(1-methyl-1H-pyrazol-5-yl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S431-1039

Molecular Formula

C24H31FN4O2 (C24 H31 FN4 O2)

Compound Name

{4-[cyclopropyl(4-fluorobenzyl)amino]-1-oxa-9-azaspiro[5.5]undec-9-yl}(1-methyl-1H-pyrazol-5-yl)methanone

IUPAC name

N-cyclopropyl-N-[(4-fluorophenyl)methyl]-9-(1-methyl-1H-pyrazole-5-carbonyl)-1-oxa-9-azaspiro[5.5]undecan-4-amine

SMILES

Cn1nccc1C(N(CC1)CCC1(C1)OCCC1N(Cc(cc1)ccc1F)C1CC1)=O

InChI

InChI=1S/C24H31FN4O2/c1-27-22(8-12-26-27)23(30)28-13-10-24(11-14-28)16-21(9-15-31-24)29(20-6-7-20)17-18-2-4-19(25)5-3-18/h2-5,8,12,20-21H,6-7,9-11,13-17H2,1H3/t21-/m0/s1

InChI Key

YFRITBXCYGQXKS-NRFANRHFSA-N

MDL Number (MFCD)

MFCD28993578

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.700

Distribution Coefficient, logD

2.646

Water Solubility, LogSw

-2.70

Polar Surface Area

39.099

Acid Dissociation Constant (pKa)

26.73

Base Dissociation Constant (pKb)

6.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

58.33

S431-1039 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S431-1039 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S431-1039?
Check Price and Availability of S431-1039, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S431-1039 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S431-1039
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S431-1039
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S431-1039 available by request